Abstract
Iron metabolism and homeostasis are imperative for the maintenance of normal physiological activities due to the element’s critical involvement in a wide variety of crucial biological processes like cellular respiration, metabolic pathways, DNA replication, repair, detoxification, neurotransmission and cellular signaling. Being a key contributor of crucial machineries regulating cellular proliferation and survival, it facilitates the process of tumor growth and development. Thus, tumor cells strive to acquire higher amount of iron than non-malignant cells to satisfy their elevated rate of metabolism. Perhaps, not surprisingly chelation of this metal ion was thought to be effective in treating cancer, but due to a variety of side effects, the use of iron chelators was clinically insignificant. However, discovery of various new classes of iron chelators with lesser side effects and selective toxicity towards cancer cells has revived the possibilities of using iron chelators in anti-cancer therapy. In this review, we have discussed the role of iron in promoting malignant mechanisms and the prospects of usage of different classes of iron chelators in cancer therapeutics.
Keywords: Cancer, homeostasis, iron chelator, iron metabolism.
Current Pharmaceutical Biotechnology
Title:Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Volume: 15 Issue: 12
Author(s): Mohsin Raza, Sankalpa Chakraborty, Monjoy Choudhury, Prahlad C. Ghosh and Alo Nag
Affiliation:
Keywords: Cancer, homeostasis, iron chelator, iron metabolism.
Abstract: Iron metabolism and homeostasis are imperative for the maintenance of normal physiological activities due to the element’s critical involvement in a wide variety of crucial biological processes like cellular respiration, metabolic pathways, DNA replication, repair, detoxification, neurotransmission and cellular signaling. Being a key contributor of crucial machineries regulating cellular proliferation and survival, it facilitates the process of tumor growth and development. Thus, tumor cells strive to acquire higher amount of iron than non-malignant cells to satisfy their elevated rate of metabolism. Perhaps, not surprisingly chelation of this metal ion was thought to be effective in treating cancer, but due to a variety of side effects, the use of iron chelators was clinically insignificant. However, discovery of various new classes of iron chelators with lesser side effects and selective toxicity towards cancer cells has revived the possibilities of using iron chelators in anti-cancer therapy. In this review, we have discussed the role of iron in promoting malignant mechanisms and the prospects of usage of different classes of iron chelators in cancer therapeutics.
Export Options
About this article
Cite this article as:
Raza Mohsin, Chakraborty Sankalpa, Choudhury Monjoy, Ghosh C. Prahlad and Nag Alo, Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer, Current Pharmaceutical Biotechnology 2014; 15 (12) . https://dx.doi.org/10.2174/138920101512141202111915
DOI https://dx.doi.org/10.2174/138920101512141202111915 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Current Neuropharmacology Cardiac Effects of Anabolic Steroids: Hypertrophy, Ischemia and Electrical Remodelling as Potential Triggers of Sudden Death
Mini-Reviews in Medicinal Chemistry Stem Cell Therapy in Heart Diseases: A Review of Selected New Perspectives,Practical Considerations and Clinical Applications
Current Cardiology Reviews Cardiac Telocytes
Current Stem Cell Research & Therapy Fibrates in the Chemical Action of Daunorubicin
Current Cancer Drug Targets Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Current Pharmaceutical Design Safety Analysis and Improved Cardiac Function Following Local Autologous Transplantation of CD133+ Enriched Bone Marrow Cells After Myocardial Infarction
Current Neurovascular Research Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety The Critical Role of Insulin-Like Growth Factor-1 Isoforms in the Physiopathology of Skeletal Muscle
Current Genomics Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Atrial Fibrillation and Hypertension: “Quo Vadis”
Current Hypertension Reviews Confocal Laser Scanning Microscope, Raman Microscopy and Western Blotting to Evaluate Inflammatory Response after Myocardial Infarction
Current Vascular Pharmacology Pharmacological Potential of Exercise and RAS Vasoactive Peptides for Prevention of Diseases
Current Protein & Peptide Science Testosterone and Cardioprotection Against Myocardial Ischemia
Cardiovascular & Hematological Disorders-Drug Targets Transition of Care for Patients with Diabetes
Current Diabetes Reviews Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety